Aquestive Therapeutics (AQST) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free AQST Stock Alerts $3.08 -0.29 (-8.59%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aquestive Therapeutics Short Interest DataCurrent Short Volume4,010,000 sharesPrevious Short Volume2,270,000 sharesChange Vs. Previous Month+76.65%Dollar Volume Sold Short$15.80 millionShort Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares91,040,000 sharesPercentage of Shares Shorted4.40%Today's Trading Volume2,745,250 sharesAverage Trading Volume2,252,633 sharesToday's Volume Vs. Average122% Short Selling Aquestive Therapeutics ? Sign up to receive the latest short interest report for Aquestive Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAQST Short Interest Over TimeAQST Days to Cover Over TimeAQST Percentage of Float Shorted Over Time Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… Aquestive Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,010,000 shares $15.80 million +76.7%N/A1.6 $3.94 3/31/20242,270,000 shares $9.67 million -2.2%N/A1 $4.26 3/15/20242,320,000 shares $14.13 million +28.2%N/A1.2 $6.09 2/29/20241,810,000 shares $6.64 million -9.1%N/A1.3 $3.67 2/15/20241,990,000 shares $5.41 million +14.4%N/A2.4 $2.72 1/31/20241,740,000 shares $4.16 million -8.4%N/A2.9 $2.39 Get the Latest News and Ratings for AQST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aquestive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,900,000 shares $5.00 million -7.3%N/A3.6 $2.63 12/31/20232,050,000 shares $4.14 million -1.0%N/A4.6 $2.02 12/15/20232,070,000 shares $4.14 million +10.1%N/A6.1 $2.00 11/30/20231,880,000 shares $4.23 million -2.1%N/A5.9 $2.25 11/15/20231,920,000 shares $3.05 million -1.5%N/A8.5 $1.59 10/31/20231,950,000 shares $3.06 million -2.0%N/A9.1 $1.57 10/15/20231,990,000 shares $3.06 million -2.0%N/A6.8 $1.54 9/30/20232,030,000 shares $3.11 million +9.7%N/A6.7 $1.53 9/15/20231,850,000 shares $3.00 million +1.7%N/A5.4 $1.62 8/31/20231,820,000 shares $2.98 million -7.1%N/A4.9 $1.64 8/15/20231,960,000 shares $3.63 million -4.4%N/A4.3 $1.85 7/31/20232,050,000 shares $4.49 million +6.2%N/A3.4 $2.19 7/15/20231,930,000 shares $3.01 million +11.6%N/A3.2 $1.56 6/30/20231,730,000 shares $2.85 million -21.7%N/A2.9 $1.65 6/15/20232,210,000 shares $4.77 million +13.3%N/A3.8 $2.16 5/31/20231,950,000 shares $4.50 million +1.6%N/A3.5 $2.31 5/15/20231,920,000 shares $4.13 million +4.4%N/A3.8 $2.15 4/30/20231,840,000 shares $2.47 million -1.6%N/A4.8 $1.34 4/15/20231,870,000 shares $2.37 million +1.1%N/A6.4 $1.27 3/31/20231,850,000 shares $2.11 million +1.1%N/A6.4 $1.14 3/15/20231,830,000 shares $1.33 million -9.9%N/A6.2 $0.73 2/28/20232,030,000 shares $1.59 million +5.7%N/A7.3 $0.78 2/15/20231,920,000 shares $1.42 million +3.8%N/A7.3 $0.74 1/31/20231,850,000 shares $1.65 million +13.5%N/A7.1 $0.89 1/15/20231,630,000 shares $1.61 million -6.3%N/A6 $0.99 12/30/20221,740,000 shares $1.57 million -6.0%N/A5.7 $0.90 12/15/20221,850,000 shares $1.67 million -19.9%N/A3.4 $0.90 11/30/20222,310,000 shares $2.14 million -4.9%N/A4.1 $0.93 11/15/20222,430,000 shares $2.55 million -7.3%N/A3.7 $1.05 10/31/20222,620,000 shares $2.28 million -0.8%N/A3 $0.87 10/15/20222,640,000 shares $2.48 million -2.2%N/A3 $0.94 9/30/20222,700,000 shares $3.16 million +134.8%N/A3.1 $1.17 9/15/20221,150,000 shares $1.48 million +17.4%N/A1.7 $1.29 8/31/2022979,200 shares $1.41 million -5.9%N/A1 $1.45348 million Americans lives to END as we know it? (Ad)348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today...To see my free research, simply click here now. AQST Short Interest - Frequently Asked Questions What is Aquestive Therapeutics' current short interest? Short interest is the volume of Aquestive Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,010,000 shares of AQST short. Learn More on Aquestive Therapeutics' current short interest. What is a good short interest ratio for Aquestive Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AQST shares currently have a short interest ratio of 2.0. Learn More on Aquestive Therapeutics's short interest ratio. Which institutional investors are shorting Aquestive Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aquestive Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Aquestive Therapeutics' short interest increasing or decreasing? Aquestive Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 4,010,000 shares, an increase of 76.7% from the previous total of 2,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aquestive Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aquestive Therapeutics: AC Immune SA (0.89%), Puma Biotechnology, Inc. (9.60%), 23andMe Holding Co. (10.48%), Verastem, Inc. (3.94%), Immutep Limited (1.66%), 2seventy bio, Inc. (13.60%), Aldeyra Therapeutics, Inc (4.17%), Pyxis Oncology, Inc. (4.78%), XBiotech Inc. (3.40%), Xeris Biopharma Holdings, Inc. (6.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Aquestive Therapeutics stock? Short selling AQST is an investing strategy that aims to generate trading profit from Aquestive Therapeutics as its price is falling. AQST shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aquestive Therapeutics? A short squeeze for Aquestive Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AQST, which in turn drives the price of the stock up even further. How often is Aquestive Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AQST, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Procaps Group Short Interest Nanobiotix Short Interest ESSA Pharma Short Interest UroGen Pharma Short Interest Vanda Pharmaceuticals Short Interest Neoleukin Therapeutics Short Interest CorMedix Short Interest Organogenesis Short Interest Akebia Therapeutics Short Interest Kamada Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AQST) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & Company